The news is by your side.

Alzheimer’s Disease

Researchers in US report promising new Alzheimer’s drug

WASHINGTON: A new experimental treatment against Alzheimer's has proved to be promising and free of harmful side effects, researchers in the United States reported Wednesday. The research published in the journal Science Translational Medicine on the basis of a small 32-person sample gave rise to two broader clinical trials that are now underway with more than 3,000 subjects. The treatment uses a compound called verubecestat, developed by US pharmaceutical firm. It reduces levels of proteins called beta amyloids by…